These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9331174)

  • 21. Incorporation and glial differentiation of mouse EGF-responsive neural progenitor cells after transplantation into the embryonic rat brain.
    Winkler C; Fricker RA; Gates MA; Olsson M; Hammang JP; Carpenter MK; Björklund A
    Mol Cell Neurosci; 1998 Jun; 11(3):99-116. PubMed ID: 9647689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effects of neurotrophin-4/5 and transforming growth factor-alpha on striatal neuronal phenotypic degeneration after excitotoxic lesioning with quinolinic acid.
    Alexi T; Venero JL; Hefti F
    Neuroscience; 1997 May; 78(1):73-86. PubMed ID: 9135090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease.
    Alexi T; Hughes PE; van Roon-Mom WM; Faull RL; Williams CE; Clark RG; Gluckman PD
    Exp Neurol; 1999 Sep; 159(1):84-97. PubMed ID: 10486177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implants of polymer-encapsulated human NGF-secreting cells in the nonhuman primate: rescue and sprouting of degenerating cholinergic basal forebrain neurons.
    Emerich DF; Winn SR; Harper J; Hammang JP; Baetge EE; Kordower JH
    J Comp Neurol; 1994 Nov; 349(1):148-64. PubMed ID: 7852623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term enhanced chromaffin cell survival and behavioral recovery in hemiparkinsonian rats with co-grafted polymer-encapsulated human NGF-secreting cells.
    Date I; Shingo T; Ohmoto T; Emerich DF
    Exp Neurol; 1997 Sep; 147(1):10-7. PubMed ID: 9294398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microtransplantation of whole ganglionic eminence cells ameliorates motor deficit, enlarges the volume of grafts, and prolongs survival in a rat model of Huntington's disease.
    Zhu M; Shu K; Wang H; Li X; Xiao Q; Chan W; Emmanuel B; Jiang W; Lei T
    J Neurosci Res; 2013 Dec; 91(12):1563-71. PubMed ID: 24105649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein regulation of induced pluripotent stem cells by transplanting in a Huntington's animal model.
    Mu S; Han L; Zhou G; Mo C; Duan J; He Z; Wang Z; Ren L; Zhang J
    Neuropathol Appl Neurobiol; 2016 Oct; 42(6):521-34. PubMed ID: 26859760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease.
    Emerich DF; Winn SR; Hantraye PM; Peschanski M; Chen EY; Chu Y; McDermott P; Baetge EE; Kordower JH
    Nature; 1997 Mar; 386(6623):395-9. PubMed ID: 9121555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transplantation of induced pluripotent stem cells improves functional recovery in Huntington's disease rat model.
    Mu S; Wang J; Zhou G; Peng W; He Z; Zhao Z; Mo C; Qu J; Zhang J
    PLoS One; 2014; 9(7):e101185. PubMed ID: 25054283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotective effects of encapsulated CNTF-producing cells in a rodent model of Huntington's disease are dependent on the proximity of the implant to the lesioned striatum.
    Emerich DF; Winn SR
    Cell Transplant; 2004; 13(3):253-9. PubMed ID: 15191163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term cortical atrophy after excitotoxic striatal lesion: effects of intrastriatal fetal-striatum grafts and implications for Huntington disease.
    Muñoz A; Lopez A; Caruncho HJ; Guerra MJ; Labandeira-García JL
    J Neuropathol Exp Neurol; 2001 Aug; 60(8):786-97. PubMed ID: 11487053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Protective effect of intrastriatal grafts in an experimental model of Huntington's disease. Behavioral and morphological correlation].
    Levivier M; Pearlman SH; Gash DM; Brotchi J
    Neurochirurgie; 1991; 37(3):148-59. PubMed ID: 1831884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease.
    Tattersfield AS; Croon RJ; Liu YW; Kells AP; Faull RL; Connor B
    Neuroscience; 2004; 127(2):319-32. PubMed ID: 15262322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neural transplantation of hNT neurons for Huntington's disease.
    Hurlbert MS; Gianani RI; Hutt C; Freed CR; Kaddis FG
    Cell Transplant; 1999; 8(1):143-51. PubMed ID: 10338282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BDNF regulation under GFAP promoter provides engineered astrocytes as a new approach for long-term protection in Huntington's disease.
    Giralt A; Friedman HC; Caneda-Ferrón B; Urbán N; Moreno E; Rubio N; Blanco J; Peterson A; Canals JM; Alberch J
    Gene Ther; 2010 Oct; 17(10):1294-308. PubMed ID: 20463759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease.
    Ryu JK; Kim J; Cho SJ; Hatori K; Nagai A; Choi HB; Lee MC; McLarnon JG; Kim SU
    Neurobiol Dis; 2004 Jun; 16(1):68-77. PubMed ID: 15207263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Embryonic striatal grafts restore neuronal activity of the globus pallidus in a rodent model of Huntington's disease.
    Nakao N; Ogura M; Nakai K; Itakura T
    Neuroscience; 1999 Jan; 88(2):469-77. PubMed ID: 10197767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delivery of GDNF by an E1,E3/E4 deleted adenoviral vector and driven by a GFAP promoter prevents dopaminergic neuron degeneration in a rat model of Parkinson's disease.
    Do Thi NA; Saillour P; Ferrero L; Dedieu JF; Mallet J; Paunio T
    Gene Ther; 2004 May; 11(9):746-56. PubMed ID: 14724667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells.
    Martínez-Serrano A; Björklund A
    J Neurosci; 1996 Aug; 16(15):4604-16. PubMed ID: 8764649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neural cells from primary human striatal xenografts migrate extensively in the adult rat CNS.
    Hurelbrink CB; Armstrong RJ; Dunnett SB; Rosser AE; Barker RA
    Eur J Neurosci; 2002 Apr; 15(7):1255-66. PubMed ID: 11982636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.